Measurement of increasing NGAL-concentration in urine and plasma can be utilized in basic research, clinical research and pre-clinical studies to evaluate the course and extend of kidney damage / nephrotoxic damage. The KIM-1 lateral flow test can be used to measure acute kidney damage in humans.
NGAL – as early AKI Biomarker
Additional information on NGAL as an early biomarker for acute kidney injury (AKI).
NGAL – Products from BioPorto Diagnostics
Here you can find information about available products for detection of NGAL and their use.
NGAL – Neutrophil gelatinase-associated lipocalin
Here you can find general information about the expression and function of the NGAL protein.